A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at The Australian National University (ANU).

DeepPT, developed in collaboration with scientists at the National Cancer Institute in America and pharmaceutical company Pangea Biomed, works by predicting a patient’s messenger RNA (mRNA) profile. This mRNA – essential for protein production – is also the key molecular information for personalised cancer medicine. 

According to lead author Dr Danh-Tai Hoang from ANU, when combined with a second tool called ENLIGHT, DeepPT was found to successfully predict a patient’s response to cancer therapies across multiple types of cancer. 

“We know that selecting a suitable treatment for cancer patients can be integral to patient outcomes,” Dr Hoang said.  

“DeepPT was trained on over 5,500 patients across 16 prevalent cancer types, including breast, lung, head and neck, cervical and pancreatic cancers.  

“We saw an improvement in patient response rate from 33.3 per cent without using our model to 46.5 per cent with using our model.” 

DeepPT builds on previous work by the same ANU researchers to develop a tool to help classify brain tumours.

Both AI tools draw on microscopic pictures of patient tissue called histopathology images, also providing another key benefit for patients. 

“This cuts down on delays in processing complex molecular data, which can take weeks,” Dr Hoang said. 

“Any kind of delay obviously poses a real challenge when dealing with patients with high-grade tumours who might require immediate treatment. 

“In contrast, histopathology images are routinely available, cost-effective and timely.” 

The study has been published in Nature Cancer.

Top image: Dr Danh-Tai Hoang. Photo: Dave Fanner/ANU

Contact the media team

Jess Fagan

Media Manager


You may also like

Article Card Image

Mates and vapes: tackling industry influence on teenage smoking

ANU PhD scholar Amelia Yazidjoglou is determined to prevent the tobacco and e-cigarette industry from targeting teenagers and addicting the next generation.

Article Card Image

Australia’s fertility rate is almost irreversible, but recovery begins with hope

The declining fertility rate in Australia is driven by socio-economic pressures. ANU expert Dr Liz Allen argues that restoring hope will require addressing a broad range of issues.

Article Card Image

White wine and lorazepam: the ‘innocent’ face of addiction

ANU research shows not all addictions are treated equally by the media. Less stigmatised reporting could save lives.

Subscribe to ANU Reporter